Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B
Background and aim: Chronic hepatitis B is a highly prevalent disease worldwide, leading to serious consequences if not properly treated. Six treatment options for chronic hepatitis B are currently provided by the Brazilian public health system. Telbivudine is a nucleoside analogue that is neither i...
Main Authors: | Astrid Wiens, M.Sc., Rafael Venson, M.D., Cassyano Januário Correr, M.Sc., Roberto Pontarolo, M.Sc. |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2011-05-01
|
Series: | Brazilian Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1413867011701805 |
Similar Items
-
Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B
by: Astrid Wiens, et al. -
Economic evaluation of treatments for chronic hepatitis B
by: Astrid Wiens, et al. -
Economic evaluation of treatments for chronic hepatitis B
by: Astrid Wiens, et al.
Published: (2013-07-01) -
Efficacy, safety and tolerability of using abatacept for the treatment of rheumatoid arthritis
by: Rafael Venson, et al.
Published: (2012-12-01) -
Assessing Efficacy, Safety and Tolerability of Rituximab for Rheumatoid Arthritis: Meta-Analyses of Randomized Controlled Trials
by: Rafael Venson, et al.
Published: (2013-12-01)